Home > Healthcare > Healthcare IT > Artificial Intelligence > Artificial Intelligence (AI) in Drug Discovery Market

Artificial Intelligence (AI) in Drug Discovery Market Share

  • Report ID: GMI6361
  • Published Date: Aug 2023
  • Report Format: PDF

AI in Drug Discovery Market Share

Major market players operating in the artificial intelligence in drug discovery market include:

  • Microsoft
  • BenevolentAI
  • Exscientia
  • IBM Corporation
  • Alphabet (DeepMind)

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Artificial intelligence in drug discovery market size was USD 1.5 billion in 2022 and is estimated to record USD 20.9 billion by end of 2032 due to the rising need to curb the drug discovery cost and time utilized in the processes

AI in drug discovery market size from the machine learning technology segment may reach USD 18 billion by 2032 owing to the higher availability and accessibility of vast amounts of data, including genomics, proteomics, and clinical records

The molecular library screening application segment held 40.1% of the artificial intelligence (AI) in drug discovery market share in 2022 driven by the surging demand for the discovery and development of novel drug therapies

North America recorded 51.9% of the artificial intelligence in drug discovery market share in 2022 and will witness considerable growth through 2032 due to the robust ecosystem of research institutions, academic centers, and healthcare facilities in the region

AI in Drug Discovery Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 328
  • Countries covered: 20
  • Pages: 220
 Download Free Sample